WATCH: Legendary NFL Quarterback Brett Favre Reveals Grim Medical Diagnosis During House Hearing

During a hearing on federal welfare reform held by the House Ways and Means Committee on Tuesday, legendary quarterback Brett Favre revealed that he has recently been diagnosed with Parkinson's disease, a disorder that impacts the central nervous system and movement.

"Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others," the 54-year-old Favre said during his opening statement. "I'm sure you'll understand, while it's too late for me because I've recently been diagnosed with Parkinson's, this is also a cause dear to my heart."

After 20 seasons in the NFL, Favre explained to the "The Bubba Army" radio show in 2022 that he had suffered thousands of concussions, and he emphasized during an interview with Megyn Kelly in 2018 that he has had difficulty with his short-term memory and word retrieval, as reported by The New York Post.

Favre spoke before the committee on his involvement with Prevacus, a company that received $2 million in Temporary Assistance for Needy Families (TANF) funding to develop a concussion drug. The company's founder, Jacob VanLandingham, was found guilty of wire fraud in July for spending the welfare funds to pay off personal debts. During his testimony, Favre, a top Prevacus investor, explained that the welfare funds were abused and used to transfer tens of millions of dollars from Mississippi's poorest residents to the rich.

WATCH:
 

You can follow Sterling on X/Twitter here.


 
READ THIS NEXT
WATCH: President Trump Gives Mom Of Three $100 During Grocery Trip - 'We’ll Do That For You From The White House'
Nebraska Governor Refuses To Call Special Session To Change To Winner-Take-All Electoral System - 'Left Every Inch On The Field'
'Shame On Her': Senator Joe Manchin SLAMS Kamala Harris For Going After The 'Holy Grail Of Democracy'
Sign in to comment

Comments

Powered by StructureCMS™ Comments

Get Updated

© 2024 DC Enquirer, Privacy Policy